Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by retiredcopon Jun 08, 2018 9:21am
150 Views
Post# 28144909

RE:RE:RE:RE:Next Climb or Drop..

RE:RE:RE:RE:Next Climb or Drop..Mitchellb I am now more coufused than I was prior to all the noise starting on this blog board. I dont think in the past 10 years I can remember taking time out to vote for anything at theis companies AGM's. now that its got my attention I have look closer at what the fine print actually says.   I am trying to figure out what exactly would we be voting for or against.. do we think we are voting that no stock options be given.. because as I read the fine print it seems to say to me that we would be voting down the stock option plan as its sits right now and that would put the responsibility on the board to now come up with a new formula... and they would have complete say on what it is... the only way to ensure that no stock options are available is to vote ih a whole new board who would be compleytely on the same page as the majority of stock holders .. example Biogen in 2009, when a majority stockholder brought in his own board ... this past 2 week there was alot of lips flapping about this . so maybe someone out there can expalin exactly what the vote is for ,, becuase many of you had made your mind up already so you must have known all the consequesnces... commm on .. help some of us out with this ..  
Bullboard Posts